iOS app Android app


Lessons from Roche's NJ Exit: Taxes Aren't the Magic Bullet for Job Creation

Gordon MacInnes | Posted 09.05.2012 | Business
Gordon MacInnes

Not even the loss of 1,000 high-paying jobs as Roche abandons its 80-year tie to New Jersey is enough to shake the one-note insistence of Gov. Chris Christie's administration that taxes are all that counts in holding and attracting jobs.

Cloud Architecture

Carla Leitao | Posted 04.16.2012 | Arts
Carla Leitao

In our office we are interested in creating a framework by which the word 'technology' can indeed be engaged through its practical corollaries -- communication and material -- in the creation of architectural and urban space.

22 Republicans, 20 Democrats Used Lobbying Firm's Statements In House Health Care Speeches

New York Times | ROBERT PEAR | Posted 05.25.2011 | Politics

Statements by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, one of the world's la...

The Possiblity of a Pandemic and the Certainty of Diseases That Kill

Richard Chin | Posted 05.25.2011 | World
Richard Chin

Diarrheal diseases, which kill approximately 2 million children under the age of five in every year continue to receive less attention than diseases like the swine flu virus.

Thinking the Unthinkable: Six (Uncomfortable) Questions about the Swine Flu Outbreak

Ben Sherwood | Posted 05.25.2011 | World
Ben Sherwood

Are there enough antiviral medicines to keep us safe? Do face masks protect against swine flu? Is the world ready for a new pandemic?

The 10 Worst Corporations of 2008

Robert Weissman | Posted 05.25.2011 | Business
Robert Weissman

In keeping with our tradition of highlighting diverse forms of corporate wrongdoing, we included only one financial company on the 10 Worst list.

Top European Drugmakers Back Stem Cell Testing

Reuters | Ben Hirschler | Posted 05.25.2011 | Business

Three of Europe's top drugmakers have backed a new public-private scheme to use stem cells for safety testing of experimental medicines, signaling "bi...